Company news
MindWalk Holdings Corp. news in 2025
MindWalk Holdings Corp.'s news releases, calls and decks from 2025, newest first.
MindWalk Reports Record Growth and Announces Strategic Progress on Its AI Asset Pipeline
December 14, 2025
MindWalk Holdings Corp. to Report Financial Results and Recent Business Highlights for Second Quarter Fiscal Year 2026 on December 15, 2025
December 8, 2025
MindWalk CTO Dr. Dirk Van Hyfte to Join Fireside Chat at AI Drug Discovery & Development Summit 2025
November 13, 2025
MindWalk Appoints R. Scott Areglado as Chief Financial Officer to Strengthen Financial Leadership and Support Growth Strategy
October 20, 2025
MindWalk Appoints Dr. Thomas W. Lynch as Chief Business Officer to Accelerate Commercial Expansion
October 14, 2025
MindWalk Announces Share Repurchase Program
October 8, 2025
MindWalk Advances AI-Designed GLP-1 Program with First-in-Class Dual-Pathway Regimen for Aging and Longevity
September 21, 2025
MindWalk Holdings Corp.™ (formerly ImmunoPrecise Antibodies™) Reports Record $7.6 Million Quarterly Revenue, 45% Growth, Margin Expansion, Narrowed Losses, and Strengthened Balance Sheet
September 14, 2025
MindWalk to Report Financial Results and Recent Business Highlights for First Quarter Fiscal Year 2026 on September 15, 2025
September 10, 2025
Calls in 2025
Decks in 2025
- Q2 2026 Earnings Presentation
Earnings · 14 slides · Dec 15, 2025
- ImmunoPrecise Antibodies — FY2025 Earnings Presentation
Earnings · 17 slides · Jul 29, 2025
- ImmunoPrecise Antibodies — Q3 FY2025 Earnings Presentation
Earnings · 16 slides · Mar 28, 2025